XML 89 R77.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue from Contracts with Customers (ASC 606) - Impact of New Revenue Guidance on Financial Statement (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Jan. 01, 2018
Dec. 31, 2015
Balance Sheet                          
Cash, cash equivalent and marketable securities $ 18,075               $ 18,075     $ 42,915  
Accounts receivable, net 29,663       $ 28,316       29,663 $ 28,316   28,316  
Inventories 22,942       22,732       22,942 22,732   22,732  
Prepaid expenses and other current assets 3,494       3,816       3,494 3,816   3,816  
Long-lived assets 95,979               95,979     92,513  
Other non-current assets 6,736       5,927       6,736 5,927   5,927  
Contract assets, long-term 6,971       0       6,971 0   5,963  
Non-current deferred income tax asset 226       20       226 20   222  
Total assets 187,652       196,239       187,652 196,239   205,609  
Accounts payable, accrued expenses, and other current liabilities 46,817               46,817     36,430  
Deferred revenue, current 0       6,919       0 6,919   0  
Contract liabilities 9,193       0       9,193 0   11,039  
Long-term contract liabilities 9,070       0       9,070 0   7,998  
Other long-term liabilities 3,620               3,620     2,653  
Long-term debt, excluding current portion 19,437       44,572       19,437 44,572   44,572  
Total liabilities 88,137       90,574       88,137 90,574   102,692  
Accumulated deficit (15,397)       (4,417)       (15,397) (4,417)   (7,165)  
Common stock, additional paid-in capital, and accumulated other comprehensive loss 114,912               114,912     110,082  
Total stockholders’ equity 99,515       105,665       99,515 105,665 $ 106,502 102,917 $ 118,176
Total liabilities and stockholders’ equity 187,652       196,239       187,652 196,239   205,609  
Consolidated Statement of Operations                          
Net sales                 170,761 160,088 176,122    
Research and development                 14,951 15,858 16,030    
Sales, marketing and support                 34,910 33,896 33,942    
General and administrative                 27,964 28,932 28,172    
Total costs and expenses                 177,925 168,852 177,444    
Loss from operations (1,877) $ (920) $ (1,187) $ (3,180) (1,125) $ (1,801) $ (1,368) $ (4,470) (7,164) (8,764) (1,322)    
Other income (expense), net                 (503) (1,174) (648)    
Loss before income tax expense                 (7,667) (9,938) (1,970)    
Income tax expense                 565 1,096 5,547    
Net loss (1,822) (1,174) (1,343) (3,893) (1,685) (2,438) (2,026) (4,885) $ (8,232) (11,034) (7,517)    
Net loss per common share, basic and diluted (in dollars per share)                 $ (0.48)        
Statement of Cash Flows                          
Net loss (1,822) $ (1,174) $ (1,343) $ (3,893) (1,685) $ (2,438) $ (2,026) $ (4,885) $ (8,232) (11,034) (7,517)    
Non-cash adjustments to reconcile net loss to net cash used in operating activities                 15,694        
Accounts receivable and inventories                 (2,357)        
Prepaid expenses, other assets, and contract assets                 (2,340)        
Deferred revenue, contract liabilities, and long-term contract liabilities                 (498) (138) 1,474    
Accounts payable, accrued compensation, warranty, other, and other long-term liabilities                 2,917        
Net cash provided by operating activities                 5,184 11,527 18,699    
Current contract assets 3,566       0       3,566 0   3,205  
Non-current contract assets 6,971       0       6,971 0   5,963  
Contract liabilities 9,193       0       9,193 0   11,039  
Long-term contract liabilities 9,070       0       9,070 0   $ 7,998  
Pro forma as if the previous accounting guidance had been in effect                          
Balance Sheet                          
Cash, cash equivalent and marketable securities 18,075       42,915       18,075 42,915      
Accounts receivable, net 29,663       28,316       29,663 28,316      
Inventories 22,942       22,732       22,942 22,732      
Prepaid expenses and other current assets 3,494       3,816       3,494 3,816      
Long-lived assets 95,979       92,513       95,979 92,513      
Other non-current assets 6,736       5,927       6,736 5,927      
Contract assets, long-term 0       0       0 0      
Non-current deferred income tax asset 86       20       86 20      
Total assets 176,975       196,239       176,975 196,239      
Accounts payable, accrued expenses, and other current liabilities 46,817       36,430       46,817 36,430      
Deferred revenue, current 4,833       6,919       4,833 6,919      
Contract liabilities 0       0       0 0      
Long-term contract liabilities 0       0       0 0      
Other long-term liabilities 3,620       2,653       3,620 2,653      
Long-term debt, excluding current portion 19,437       44,572       19,437 44,572      
Total liabilities 74,707       90,574       74,707 90,574      
Accumulated deficit (12,644)       (4,417)       (12,644) (4,417)      
Common stock, additional paid-in capital, and accumulated other comprehensive loss 114,912       110,082       114,912 110,082      
Total stockholders’ equity 102,268       105,665       102,268 105,665      
Total liabilities and stockholders’ equity 176,975       196,239       176,975 196,239      
Consolidated Statement of Operations                          
Net sales                 172,072        
Research and development                 14,951        
Sales, marketing and support                 35,022        
General and administrative                 27,964        
Total costs and expenses                 179,294        
Loss from operations                 (7,222)        
Other income (expense), net                 (503)        
Loss before income tax expense                 (7,725)        
Income tax expense                 502        
Net loss                 $ (8,227)        
Net loss per common share, basic and diluted (in dollars per share)                 $ (0.48)        
Statement of Cash Flows                          
Net loss                 $ (8,227)        
Non-cash adjustments to reconcile net loss to net cash used in operating activities                 15,631        
Accounts receivable and inventories                 (2,357)        
Prepaid expenses, other assets, and contract assets                 (971)        
Deferred revenue, contract liabilities, and long-term contract liabilities                 (1,809)        
Accounts payable, accrued compensation, warranty, other, and other long-term liabilities                 2,917        
Net cash provided by operating activities                 5,184        
Current contract assets 0       0       0 0      
Non-current contract assets 0       0       0 0      
Contract liabilities 0       0       0 0      
Long-term contract liabilities $ 0       $ 0       0 0      
Product                          
Consolidated Statement of Operations                          
Net sales                 63,277 56,968 73,075    
Cost of product and service sales                 39,510 37,474 46,334    
Product | Pro forma as if the previous accounting guidance had been in effect                          
Consolidated Statement of Operations                          
Net sales                 64,588        
Cost of product and service sales                 40,767        
Service                          
Consolidated Statement of Operations                          
Net sales                 107,484 103,120 103,047    
Cost of product and service sales                 60,590 $ 52,692 $ 52,966    
Service | Pro forma as if the previous accounting guidance had been in effect                          
Consolidated Statement of Operations                          
Net sales                 107,484        
Cost of product and service sales                 $ 60,590